Stroke & Interventional Neurology. Neuroscience & Stroke Director, Mercy Health. Ischemic & hemorrhagic stroke research.
Toledo, OH
Joined May 2017
- Tweets526
- Following1.6K
- Followers3K
- Likes12.1K
Osama Zaidat MD retweeted
SEAL Technology - Two configurations. One SEAL.
Shared architecture. Distinct height behaviours.
SEAL ARC and SEAL Base: two configurations to match aneurysm height and morphology.
JUST SEAL IT.
#SEAL #GalaxyTherapeutics
SEAL is not approved for sale in the US
Osama Zaidat MD retweeted
SEAL Commercial update - SEAL IT at WFITN 2026
In Busan? Join Dr. David Altschul, SEAL IT PI, for the Galaxy SEAL-iT Trial Update.
Tomorrow, Oct 12 | 15:00–15:20 KST
Main Hall, BEXCO | SS-AN-04
#SEAL #GalaxyTherapeutics #WFITN2026
Osama Zaidat MD retweeted
Congratulations Dr Marc Moisi and @MINeuroSurgeons for a great Neurosurgery meeting. Great to see colleagues @umichneuro presenting their work! Congratulations to all for a fantastic gathering!
Osama Zaidat MD retweeted
Investing in emerging talent is investing in the future of MedTech.
We proudly recognize Galaxy Therapeutics’ Intern Class of 2025–2026 for their curiosity, commitment and contributions.
Thank you, Amy, Sophia, Eddie, Krish, Henry and Maya!
#FutureTalent #MedTech
🤖 Made with AI
Osama Zaidat MD retweeted
Galaxy Reception - Marseille
Join us on September 3 at 16:30 during #ESMINT2026 as we celebrate the European launch of the SEAL™ Embolization System.
Attendance is limited.
RSVP ↓
luma.com/rkid1axl
Marseille, here we go! 🇫🇷
#GalaxyReception #Neurointervention
An amazing day in the Galaxy journey! 🚀 We got our CE mark, reflecting the dedication of our GT team and close to 500 patients worldwide.
Excited to partner with EU & global interventionalists to bring the SEAL to their toolbox! 🧠✨
Osama Zaidat MD retweeted
Galaxy Therapeutics has achieved CE Mark for the SEAL™ Embolization System—enabling commercial launch across Europe and international markets.
A major milestone in expanding access to innovative brain aneurysm treatment.
Read more: l1nq.com/aqoarii
Osama Zaidat MD retweeted
Another important milestone on our journey toward FDA approval.
This week, we welcomed the FDA for another key inspection at our Milpitas HQ.
We’d like to recognize and thank our R&D, Engineering, Manufacturing, Quality, Operations, and MedX CRO teams.
#GalaxyTherapeutics
Osama Zaidat MD retweeted
Congrats @oozaidat and everyone involved. Huge accomplishment by a great team.
Osama Zaidat MD retweeted
Here we go- Congratulations @oozaidat and team 🔥
Galaxy Therapeutics has submitted the final PMA module to the U.S. FDA for SEAL™ in WNBA subgroup.
prnewswire.com/news-releases…
#GalaxyTherapeutics #SEAL #SEALIT
Osama Zaidat MD retweeted
Love it ❤️ 💪
Thank you @SVINJournal for highlighting our paper 🙏
@ZRosensteinMED
@Mo_majali91
@AshouriYazan
@oozaidat
Paclitaxel Drug-Coated Balloon Angioplasty for Medically Refractory Intracranial Atherosclerotic Disease: A US Single-Center Experience With the AGENT Balloon
ahajrnls.org/4t21ZV4
Osama Zaidat MD retweeted
.@GalaxyThera has announced the submission of the final module of its PMA application to the @US_FDA for the Seal device for the treatment of wide-neck bifurcation aneurysms
@oozaidat
neuronewsinternational.com/g…
Osama Zaidat MD retweeted
Paclitaxel Drug-Coated Balloon Angioplasty for Medically Refractory Intracranial Atherosclerotic Disease: A US Single-Center Experience With the AGENT Balloon
ahajrnls.org/4t21ZV4
Osama Zaidat MD retweeted
Can we update the graphic abstract because this is not the correct one @SVINJournal
Osama Zaidat MD retweeted
Congrats and thank you to Dr. @dockhandelwal, Dr. Amit Singla, Dr. Fadar Otite, Dr. Nemanja Novakovic, Dr. @NaderElSeblani and the entire @RutgersU team for enrolling their 5th subject in the #PICASSO trial! 🎉🎉 @oozaidat @samialkasab @NguyenThanhMD
Osama Zaidat MD retweeted
Congrats and thank you to Dr. @DrMichaelLevitt, Dr. Melanie Walker, Dr. @Steph_ChenMD, Dr. Basavaraj Ghodke and the entire @UW team for enrolling their debut subject in the #PICASSO trial! 🎉 @oozaidat @samialkasab @NguyenThanhMD
Osama Zaidat MD retweeted
Congrats and thank you to Dr. Saad Hasan, Dr. @drjoshabecassis and the entire @uofl team for enrolling their 3rd subject in the #PICASSO trial! 🎉 @oozaidat @samialkasab @NguyenThanhMD
Osama Zaidat MD retweeted
Congrats and thank you to Dr. Amer Alshekhlee, Dr. Chizoba Ezepue, and the entire @SSMHealth team for enrolling their 5th subject in the #PICASSO trial! 🎉 #ClinicalTrial #stroke @oozaidat @samialkasab @NguyenThanhMD
Osama Zaidat MD retweeted
Congrats and thank you to Dr. @evanluthermd, Dr. Russell Cerejo, Dr. Scott Ruskin, Dr. @romilsingh1892, Dr. Seung Jeong, Dr. Andrew Ku, and the rest of the @AHNtoday team for enrolling their 9th subject in the #PICASSO trial! #ClinicalTrial @oozaidat @samialkasab @NguyenThanhMD
Osama Zaidat MD retweeted
Congrats and to Dr. @TareqKass, Dr. Michael Hurley,and the rest of the @UChicago team for enrolling their 15th subject and the 200th subject overall in the #PICASSO trial! 🎉 #ClinicalTrial #stroke
@oozaidat @samialkasab @NguyenThanhMD
